植物固醇 Phytosterols × 血脂異常／膽固醇
The claim under evaluation is narrow and surrogate-only: does dietary intake of phytosterols (plant sterols/stanols, ~1.
The claim under evaluation is narrow and surrogate-only: does dietary intake of phytosterols (plant sterols/stanols, ~1.5-3 g/day) lower the blood LDL-cholesterol level. On that exact question the evidence is strong, reproducible and quantitatively concordant across every source tier. Examine grades the largest LDL body of evidence A (Metabolic Health / General Cardiovascular Health: LDL across 112 studies / 6,500 participants, Moderate Improvement). Four large independent meta-analyses converge tightly: Demonty 2009 (84 RCTs, 141 arms) -8.8% LDL at 2.15 g/day; AbuMweis 2008 (59 RCTs, >4,500 participants, academic-funded) -0.31 mmol/L dose-dependently; Ras 2014 (124 RCTs, 201 strata) 6-12% across 0.6-3.3 g/day; Fontane 2023 (125 studies, academic-funded) -0.55 mmol/L. The US FDA holds an SSA-standard AUTHORIZED health claim (21 CFR 101.83 — the highest FDA tier, not merely a qualified claim), and the EU has formally AUTHORISED an Article 14 disease-risk-reduction claim (EFSA Journal 2008;781, 2009;1175, quantified by Reg. 686/2014: 7-10.5% at 1.5-2.4 g/day, ~11.3% at 3 g/day). Mayo (5-15% at 2 g/day), Cleveland Clinic (8-10% at 2 g/day), the National Lipid Association (recommends ~2 g/day adjunct) and AHA all explicitly affirm the LDL numbers move. I therefore independently grade the LDL-lowering claim A, matching Examine's strongest body of evidence. The A grade is capped at the surrogate level only: LDL-C is a surrogate marker and NO randomized trial has demonstrated a reduction in hard cardiovascular events, myocardial infarction, stroke or mortality with phytosterols; Examine itself has no clinical-endpoint cholesterol outcome (all 21 cholesterol outcomes are surrogate). The A grade is for lowering LDL numbers, not for proven clinical CVD benefit.
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.743
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 1 negative)
- tier_strict_requirement_check — | A→B 因 L4 有 ≥1 against
- detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
台灣社群討論降膽固醇時，焦點壓倒性地落在紅麴與納豆激酶，植物固醇被提及的頻率明顯偏低、缺乏專屬的實測心得串。少數提到者多為轉述「能在腸道與膽固醇搶位置」的機轉，或來自添加植物固醇的乳飲（倍樂醇 Benecol）行銷話術。鄉民對保健品降膽固醇普遍存疑，常見論調是『有藥指數高就吃藥，保健品效果不顯著』。整體在地真實使用經驗稀薄，多數討論被廠商部落格與業配文佔據。
無共識（社群討論稀薄，植物固醇被紅麴／納豆嚴重蓋過，缺少多人一致的實測回饋）
依論壇被提及頻率，非銷售或品質排序。
- 倍樂醇 Benecol（添加植物固醇乳飲，社群／廣告能見度最高）
- 悠活原力 YohoPower（植物固醇保健品牌，多見於部落格推薦文）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 心臟健康飲食型態
- 生活型態調整（規律運動、健康體重、戒菸）
- 史他汀類降血脂藥物
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-cholesterol-INT-phytosterols-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "植物固醇能改善血脂異常／膽固醇",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}